We were part of a £1.6 million collaboration, which examined rapid testing to guide treatment for patients in intensive care.

Problem

Invasive candidiasis is the most common fungal infection affecting patients…

In partnership with the North East Innovation Lab, we are collaborating with ExGen Dx and supporting the development and evaluation of their test for…

Advancing diagnostic tests and shaping the most effective treatment has taken a step forward for patients thanks to a £2.56m award for a collaboration between industry, Newcastle Hospitals and…

Working with the Cystic Fibrosis community, we have produced a document to guide future diagnostic research and development.

Problem

Cystic fibrosis (CF) affects about 11,000 people in the UK. People living…

The NIHR has awarded Newcastle close to £3M of government funding to develop and evaluate new innovative technology solutions for better diagnosis for people across the country.

The funding from…

Opportunity to ensure that new diagnostics for lung infections are aligned with the needs of people living with cystic fibrosis.

Cystic Fibrosis (CF) is an inherited, chronic and progressive condition…

The NIHR Newcastle MIC are part of a national partnership awarded over £200,000 to design a platform for assessing tests that aim to steer antibiotic treatment.

Every…

Faster diagnosis of flu in hospitals, using tests like the Alere i Influenza A & B NPT, could save the NHS money.

Problem

Influenza (flu) can cause severe illness in certain…

The MR-proADM test could help to identify patients with an infection who are deteriorating and at risk of sepsis.

Problem

Patients admitted to hospital with an infection are monitored using clinical…

Delighted to share that the North East Innovation Lab, part of Newcastle Hospitals, has achieved a major milestone with accreditation to an international standard.

The lab has been awarded accreditation…

We have helped the UK based company Paragraf obtain over £500,000 from Innovate UK to develop their rapid test for distinguishing between viral…

We have helped an international team, led by the University of Edinburgh, obtain £3 million funding and explored the need for their new diagnostic.

Problem

Ventilator associated pneumonia (VAP) affects 20%…